Patents by Inventor Gowri Sukumar

Gowri Sukumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of tegavivint
    Patent number: 11964054
    Abstract: Formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: April 23, 2024
    Assignee: Iterion Therapeutics, Inc.
    Inventors: Gowri Sukumar, Drazen Ostovic
  • LYOPHILIZED FORMULATIONS OF TEGAVIVINT
    Publication number: 20240074977
    Abstract: Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Application
    Filed: October 24, 2023
    Publication date: March 7, 2024
    Inventors: Gowri Sukumar, Drazen Ostovic
  • Lyophilized formulations of tegavivint
    Patent number: 11793759
    Abstract: Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Grant
    Filed: June 23, 2021
    Date of Patent: October 24, 2023
    Assignee: ITERION THERAPEUTICS, INC.
    Inventors: Gowri Sukumar, Drazen Ostovic
  • FORMULATIONS OF TEGAVIVINT
    Publication number: 20230190659
    Abstract: Formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Application
    Filed: February 6, 2023
    Publication date: June 22, 2023
    Inventors: Gowri Sukumar, Drazen Ostovic
  • Lyophilized formulations of tegavivint
    Patent number: 11602501
    Abstract: Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Grant
    Filed: October 4, 2021
    Date of Patent: March 14, 2023
    Assignee: Iterion Therapeutics, Inc.
    Inventors: Gowri Sukumar, Drazen Ostovic
  • Lyophilized formulations of tegavivint
    Patent number: 11571388
    Abstract: Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: February 7, 2023
    Assignee: Iterion Therapeutics, Inc.
    Inventors: Gowri Sukumar, Drazen Ostovic
  • LYOPHILIZED FORMULATIONS OF TEGAVIVINT
    Publication number: 20220160635
    Abstract: Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Application
    Filed: November 24, 2020
    Publication date: May 26, 2022
    Inventors: Gowri Sukumar, Drazen Ostovic
  • LYOPHILIZED FORMULATIONS OF TEGAVIVINT
    Publication number: 20220160637
    Abstract: Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Application
    Filed: October 4, 2021
    Publication date: May 26, 2022
    Inventors: Gowri Sukumar, Drazen Ostovic
  • LYOPHILIZED FORMULATIONS OF TEGAVIVINT
    Publication number: 20220160636
    Abstract: Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
    Type: Application
    Filed: June 23, 2021
    Publication date: May 26, 2022
    Inventors: Gowri Sukumar, Drazen Ostovic
  • CRYSTALLINE FORM OF TEGAVIVINT, METHOD OF PREPARATION, AND USE THEREOF
    Publication number: 20220098173
    Abstract: The present invention relates to crystalline forms of (9E,10E)-2,7-bis((3,5-dimethylpiperidin-1-yl)sulfonyl)anthracene-9,10-dione dioxime, pharmaceutical compositions comprising the crystalline form, processes for preparing the crystalline form and methods of use therefore.
    Type: Application
    Filed: September 29, 2021
    Publication date: March 31, 2022
    Inventors: Drazen Ostovic, Gowri Sukumar
  • Crystalline form of tegavivint, method of preparation, and use thereof
    Patent number: 11136307
    Abstract: The present invention relates to crystalline forms of (9E,10E)-2,7-bis((3,5-dimethylpiperidin-1-yl)sulfonyl)anthracene-9,10-dione dioxime, pharmaceutical compositions comprising the crystalline form, processes for preparing the crystalline form and methods of use therefore.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: October 5, 2021
    Assignee: ITERION THERAPEUTICS, INC.
    Inventors: Drazen Ostovic, Gowri Sukumar